Departamento de Investigación en Hiperreactividad Bronquial, Instituto Nacional de Enfermedades Respiratorias, México DF, México.
Clin Exp Allergy. 2010 Feb;40(2):327-38. doi: 10.1111/j.1365-2222.2009.03412.x. Epub 2009 Dec 3.
A possible role of 5-hydroxytryptamine (5-HT) in the origin of antigen-induced airway hyperresponsiveness (AI-AHR) has been scarcely investigated.
To explore the participation of different 5-HT receptors in the development of AI-AHR in guinea-pigs.
Lung resistance was measured in anaesthetized guinea-pigs sensitized to ovalbumin (OVA). Dose-response curves to intravenous (i.v.) acetylcholine (ACh) were performed before and 1 h after antigenic challenge and expressed as the 200% provocative dose (PD(200)). Organ bath experiments, confocal microscopy and RT-PCR were additionally used. The 5-HT content in lung homogenates was measured by HPLC.
Antigenic challenge significantly decreased PD(200), indicating the development of AI-AHR. This hyperresponsiveness was abolished by a combination of methiothepin (5-HT(1)/5-HT(2)/5-HT(5)/5-HT(6)/5-HT(7) receptors antagonist) and tropisetron (5-HT(3)/5-HT(4) antagonist). Other 5-HT receptor antagonists showed three different patterns of response. Firstly, WAY100135 (5-HT(1A) antagonist) and ondansetron (5-HT(3) antagonist) did not modify the AI-AHR. Secondly, SB269970 (5-HT(7) antagonist), GR113808 (5-HT(4) antagonist), tropisetron or methiothepin abolished the AI-AHR. Thirdly, ketanserin (5-HT(2A) antagonist) produced airway hyporresponsiveness. Animals with bilateral vagotomy did not develop AI-AHR. Experiments in tracheal rings showed that pre-incubation with LP44 or cisapride (agonists of 5-HT(7) and 5-HT(4) receptors, respectively) induced a significant increase of the cholinergic contractile response to the electrical field stimulation. In sensitized lung parenchyma strips, ketanserin diminished the contractile responses to ACh. Sensitization was associated with a ninefold increase in the 5-HT content of lung homogenates. Confocal microscopy showed that sensitization enhanced the immunolabelling and co-localization of nicotinic receptor and 5-HT in airway epithelium, probably located in pulmonary neuroendocrine cells (PNECs). RT-PCR demonstrated that neither sensitization nor antigen challenge modified the 5-HT(2A) receptor mRNA levels.
Our results suggested that 5-HT was involved in the development of AI-AHR to ACh in guinea-pigs. Specifically, 5-HT(2A), 5-HT(4) and 5-HT(7) receptors seem to be particularly involved in this phenomenon. Participation of 5-HT might probably be favoured by the enhancement of the PNECs 5-HT content observed after sensitization.
5-羟色胺(5-HT)在抗原诱导的气道高反应性(AI-AHR)的起源中可能发挥作用,但这一作用尚未得到充分研究。
探讨不同 5-HT 受体在豚鼠 AI-AHR 发展中的作用。
在卵清蛋白(OVA)致敏的麻醉豚鼠中测量肺阻力。在抗原挑战前和 1 小时后进行静脉(i.v.)乙酰胆碱(ACh)剂量反应曲线测定,并表示为 200%激发剂量(PD(200))。还进行了器官浴实验、共聚焦显微镜和 RT-PCR。通过 HPLC 测量肺匀浆中的 5-HT 含量。
抗原挑战显著降低了 PD(200),表明 AI-AHR 的发展。这种高反应性被 methiothepin(5-HT(1)/5-HT(2)/5-HT(5)/5-HT(6)/5-HT(7)受体拮抗剂)和 tropisetron(5-HT(3)/5-HT(4)拮抗剂)的联合使用所消除。其他 5-HT 受体拮抗剂表现出三种不同的反应模式。首先,WAY100135(5-HT(1A)拮抗剂)和 ondansetron(5-HT(3)拮抗剂)并未改变 AI-AHR。其次,SB269970(5-HT(7)拮抗剂)、GR113808(5-HT(4)拮抗剂)、tropisetron 或 methiothepin 消除了 AI-AHR。第三,ketanserin(5-HT(2A)拮抗剂)引起气道低反应性。双侧迷走神经切断术的动物不会发生 AI-AHR。气管环实验表明,预孵育 LP44 或 cisapride(5-HT(7)和 5-HT(4)受体激动剂)可显著增加对电刺激的胆碱能收缩反应。在致敏的肺组织条中,ketanserin 减少了对 ACh 的收缩反应。致敏导致肺匀浆中 5-HT 含量增加了九倍。共聚焦显微镜显示,致敏增强了气道上皮中烟碱受体和 5-HT 的免疫标记和共定位,可能位于肺神经内分泌细胞(PNECs)中。RT-PCR 表明,致敏或抗原挑战均未改变 5-HT(2A)受体 mRNA 水平。
我们的结果表明,5-HT 参与了豚鼠对 ACh 的 AI-AHR 的发展。具体而言,5-HT(2A)、5-HT(4)和 5-HT(7)受体似乎特别参与了这一现象。5-HT 的参与可能得益于致敏后观察到的 PNECs 5-HT 含量的增加。